IM Cannabis (IMCC) Change in Intangibles (2020 - 2021)

IM Cannabis' (IMCC) quarterly Change in Intangibles came in at -$9520.0 in Q4 2021, down 1341.12% year-on-year from $767.05 in Q4 2020, and down 1341.12% quarter-over-quarter from $767.05 in Q4 2020.

IM Cannabis (IMCC) Change in Intangibles (2020 - 2021) Analysis & Trends

IM Cannabis' Change in Intangibles history runs 2 years deep, the most recent figure standing at -$9520.0 for Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -107.94 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 IM Cannabis 591,792.44 -193,562.09 1.03 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 -9,520.03
Dec 31, 2021 -9,520.03
Dec 31, 2020 767.05
Dec 31, 2020 767.05